Annual Interest Coverage Ratio
31.79
+12.22+62.44%
December 31, 2024
Summary
- As of February 24, 2025, HALO annual interest coverage ratio is 31.79, with the most recent change of +12.22 (+62.44%) on December 31, 2024.
- During the last 3 years, HALO annual interest coverage ratio has fallen by -2.23 (-6.55%).
- HALO annual interest coverage ratio is now -6.55% below its all-time high of 34.02, reached on December 31, 2021.
Performance
HALO Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Coverage Ratio
40.25
+2.75+7.33%
December 31, 2024
Summary
- As of February 24, 2025, HALO quarterly interest coverage ratio is 40.25, with the most recent change of +2.75 (+7.33%) on December 31, 2024.
- Over the past year, HALO quarterly interest coverage ratio has stayed the same.
- HALO quarterly interest coverage ratio is now -24.40% below its all-time high of 53.24, reached on June 30, 2021.
Performance
HALO Quarterly Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Coverage Ratio Formula
Interest Coverage Ratio = EBIT
Interest Expense
EBIT
Interest Expense
Interest Expense
HALO Interest Coverage Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +62.4% | 0.0% |
| 3 y3 years | -6.5% | +70.6% |
| 5 y5 years | +710.2% | +70.6% |
HALO Interest Coverage Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.5% | +102.6% | -7.0% | +277.2% |
| 5 y | 5-year | -6.5% | +710.2% | -24.4% | +588.5% |
| alltime | all time | -6.5% | +229.8% | -24.4% | +237.7% |
Halozyme Therapeutics Interest Coverage Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | 31.79(+62.4%) | 40.25(+7.3%) |
| Sep 2024 | - | 37.50(+38.7%) |
| Jun 2024 | - | 27.03(+21.2%) |
| Mar 2024 | - | 22.31(+9.5%) |
| Dec 2023 | 19.57(+24.7%) | 20.38(-13.6%) |
| Sep 2023 | - | 23.59(+8.6%) |
| Jun 2023 | - | 21.73(+73.8%) |
| Mar 2023 | - | 12.50(-24.2%) |
| Dec 2022 | 15.69(-53.9%) | 16.49(+52.5%) |
| Sep 2022 | - | 10.81(+1.3%) |
| Jun 2022 | - | 10.67(-75.4%) |
| Mar 2022 | - | 43.30(+56.5%) |
| Dec 2021 | 34.02(+362.9%) | 27.67(-36.0%) |
| Sep 2021 | - | 43.25(-18.8%) |
| Jun 2021 | - | 53.24(+248.2%) |
| Mar 2021 | - | 15.29(-1.7%) |
| Dec 2020 | 7.35(-241.1%) | 15.55(+88.0%) |
| Sep 2020 | - | 8.27(+34.0%) |
| Jun 2020 | - | 6.17(-4507.1%) |
| Mar 2020 | - | -0.14(-98.3%) |
| Dec 2019 | -5.21(+52.3%) | -8.24(-25.3%) |
| Sep 2019 | - | -11.03(+140.3%) |
| Jun 2019 | - | -4.59(-392.4%) |
| Mar 2019 | - | 1.57(+201.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -3.42(-190.0%) | 0.52(-109.5%) |
| Sep 2018 | - | -5.50(+45.1%) |
| Jun 2018 | - | -3.79(-10.0%) |
| Mar 2018 | - | -4.21(-118.1%) |
| Dec 2017 | 3.80(-192.7%) | 23.27(+1354.4%) |
| Sep 2017 | - | 1.60(-135.4%) |
| Jun 2017 | - | -4.52(-9.6%) |
| Mar 2017 | - | -5.00(+25.9%) |
| Dec 2016 | -4.10(-21.2%) | -3.97(-7.0%) |
| Sep 2016 | - | -4.27(+5.2%) |
| Jun 2016 | - | -4.06(-1.2%) |
| Mar 2016 | - | -4.11(-195.1%) |
| Dec 2015 | -5.20(-53.8%) | 4.32(-124.3%) |
| Sep 2015 | - | -17.80(-636.1%) |
| Jun 2015 | - | 3.32(-131.2%) |
| Mar 2015 | - | -10.63(+275.6%) |
| Dec 2014 | -11.25(-54.1%) | -2.83(-79.4%) |
| Sep 2014 | - | -13.74(+34.4%) |
| Jun 2014 | - | -10.22(-44.1%) |
| Mar 2014 | - | -18.29(-37.4%) |
| Dec 2013 | -24.50 | -29.24(+34.7%) |
| Sep 2013 | - | -21.70(-16.5%) |
| Jun 2013 | - | -25.99(+19.5%) |
| Mar 2013 | - | -21.75 |
FAQ
- What is Halozyme Therapeutics annual interest coverage ratio?
- What is the all time high annual interest coverage ratio for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual interest coverage ratio year-on-year change?
- What is Halozyme Therapeutics quarterly interest coverage ratio?
- What is the all time high quarterly interest coverage ratio for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly interest coverage ratio year-on-year change?
What is Halozyme Therapeutics annual interest coverage ratio?
The current annual interest coverage ratio of HALO is 31.79
What is the all time high annual interest coverage ratio for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual interest coverage ratio is 34.02
What is Halozyme Therapeutics annual interest coverage ratio year-on-year change?
Over the past year, HALO annual interest coverage ratio has changed by +12.22 (+62.44%)
What is Halozyme Therapeutics quarterly interest coverage ratio?
The current quarterly interest coverage ratio of HALO is 40.25
What is the all time high quarterly interest coverage ratio for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly interest coverage ratio is 53.24
What is Halozyme Therapeutics quarterly interest coverage ratio year-on-year change?
Over the past year, HALO quarterly interest coverage ratio has changed by 0.00 (0.00%)